Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Cd8a monoclonal antibody, clone 53-6.7 (APC)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Mouse |
| Host species | Rat |
| Applications | Flow Cyt |
More info about Cd8a monoclonal antibody, clone 53-6.7 (APC)
| Brand: | Abnova |
| Reference: | MAB5130 |
| Product name: | Cd8a monoclonal antibody, clone 53-6.7 (APC) |
| Product description: | Rat monoclonal antibody raised against native Cd8a. |
| Clone: | 53-6.7 |
| Isotype: | IgG2a |
| Gene id: | 12525 |
| Gene name: | Cd8a |
| Gene alias: | BB154331|Ly-2|Ly-35|Ly-B|Lyt-2 |
| Gene description: | CD8 antigen, alpha chain |
| Immunogen: | Native purified Cd8a from mouse spleen cells. |
| Form: | Liquid |
| Concentration: | 0.1 mg/mL |
| Recommend dilutions: | Flow Cytometry (3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.2% BSA, 0.09% sodium azide) |
| Storage instruction: | Store in the dark at 4°C. Do not freeze. Avoid prolonged exposure to light. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Conjugate tag: | APC |
| Product type: | Primary antibodies |
| Host species: | Rat |
| Antigen species / target species: | Mouse |
| Specificity: | This antibody recognizes mouse CD8a (32-34 KDa; alpha chain of the CD8 antigen). |
| Reactivity: | Mouse |
| Applications: | Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells.Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkotter C, Scharffetter-Kochanek K. J Clin Invest. 2002 Jan;109(2):183-92. |